Chardan Capital raises Taysha Gene's PT to $12, maintains Buy rating.

jueves, 19 de marzo de 2026, 2:32 pm ET1 min de lectura
TSHA--

Chardan Capital raises Taysha Gene's PT to $12, maintains Buy rating.

Chardan Capital raises Taysha Gene's PT to $12, maintains Buy rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios